Trial intelligence / Profile preview

Metabolic and Vascular Effects of Statins in Diabetic Patients

NCT00854503Phase 3Completed

Sponsor
University of Rome Tor Vergata
Start
Sep 2008
Primary completion
Mar 2010
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of rosuvastatin in dyslipidemia, sponsored by University of Rome Tor Vergata. Started Sep 2008; status: completed.

02

Drugs

rosuvastatin
03

Conditions

dyslipidemia

Beyond the preview

Go deeper on NCT00854503.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00854503.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call